Daniel McGahn
Vorstandsvorsitzender bei AMERICAN SUPERCONDUCTOR CORPORATION
Vermögen: 20 Mio $ am 31.05.2024
Aktive Positionen von Daniel McGahn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Vorsitzender | 01.07.2018 | - |
| Vorstandsvorsitzender | 16.06.2011 | - | |
| Präsident | 16.12.2009 | - | |
| Direktor/Vorstandsmitglied | 16.06.2011 | 01.07.2018 | |
| Geschäftsführer | 16.12.2009 | 22.11.2011 |
Karriereverlauf von Daniel McGahn
Ehemalige bekannte Positionen von Daniel McGahn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EXRO TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 27.07.2017 | 19.08.2021 |
| Independent Dir/Board Member | 27.07.2017 | 19.08.2021 | |
Konarka Technologies, Inc.
 Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Vertrieb & Marketing | 01.01.2003 | 01.01.2006 |
BioDE Ventures Ltd.
 BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 28.07.2017 | - |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Geschäftsführer | - | - |
Ausbildung von Daniel McGahn
| Massachusetts Institute of Technology | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
Operativ
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
| Sales & Marketing | 1 |
Sektoral
| Producer Manufacturing | 4 |
| Electronic Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Producer Manufacturing |
| EXRO TECHNOLOGIES INC. | Producer Manufacturing |
| Private Unternehmen | 3 |
|---|---|
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Electronic Technology |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Daniel McGahn
- Erfahrung